Acknowledgement
This study was supported by a grant from the Dongkook Pharm., Seoul, Korea.
References
- El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011;365:1118-1127 https://doi.org/10.1056/NEJMra1001683
- Korean Liver Cancer Study Group (KLCSG), National Cancer Center, Korea (NCC). 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol 2015;16:465-522 https://doi.org/10.3348/kjr.2015.16.3.465
- Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet 2018;391:1301-1314 https://doi.org/10.1016/S0140-6736(18)30010-2
- Varela M, Real MI, Burrel M, Forner A, Sala M, Brunet M, et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 2007;46:474-481 https://doi.org/10.1016/j.jhep.2006.10.020
- Sergio A, Cristofori C, Cardin R, Pivetta G, Ragazzi R, Baldan A, et al. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness. Am J Gastroenterol 2008;103:914-921 https://doi.org/10.1111/j.1572-0241.2007.01712.x
- Grainger RG. Intravascular contrast media. Br J Radiol 1982;55:544
- McClennan BL, Stolberg HO. Intravascular contrast media. Ionic versus nonionic: current status. Radiol Clin North Am 1991;29:437-454 https://doi.org/10.1016/S0033-8389(22)02711-7
- Stolberg HO, McClennan BL. Ionic versus nonionic contrast use. Curr Probl Diagn Radiol 1991;20:47-88 https://doi.org/10.1016/0363-0188(91)90018-W
- Wolf GL, Arenson RL, Cross AP. A prospective trial of ionic vs nonionic contrast agents in routine clinical practice: comparison of adverse effects. AJR Am J Roentgenol 1989;152:939-944 https://doi.org/10.2214/ajr.152.5.939
- Saade C, Deeb IA, Mohamad M, Al-Mohiy H, El-Merhi F. Contrast medium administration and image acquisition parameters in renal CT angiography: what radiologists need to know. Diagn Interv Radiol 2016;22:116-124 https://doi.org/10.5152/dir.2015.15219
- Faggioni L, Gabelloni M. Iodine concentration and optimization in computed tomography angiography: current issues. Invest Radiol 2016;51:816-822 https://doi.org/10.1097/RLI.0000000000000283
- Imai N, Ishigami M, Ishizu Y, Kuzuya T, Honda T, Hayashi K, et al. Transarterial chemoembolization for hepatocellular carcinoma: a review of techniques. World J Hepatol 2014;6:844-850 https://doi.org/10.4254/wjh.v6.i12.844
- Behrendt FF, Pietsch H, Jost G, Palmowski M, Gunther RW, Mahnken AH. Identification of the iodine concentration that yields the highest intravascular enhancement in MDCT angiography. AJR Am J Roentgenol 2013;200:1151-1156 https://doi.org/10.2214/AJR.12.8984
- Kim EY, Yeh DW, Choe YH, Lee WJ, Lim HK. Image quality and attenuation values of multidetector CT coronary angiography using high iodine-concentration contrast material: a comparison of the use of iopromide 370 and iomeprol 400. Acta Radiol 2010;51:982-989 https://doi.org/10.3109/02841851.2010.509740
- Awai K, Inoue M, Yagyu Y, Watanabe M, Sano T, Nin S, et al. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT. Radiology 2004;233:682-688 https://doi.org/10.1148/radiol.2333031617
- Andreini D, Pontone G, Mushtaq S, Bartorelli AL, Conte E, Bertella E, et al. Coronary stent evaluation with coronary computed tomographic angiography: comparison between low-osmolar, high-iodine concentration iomeprol-400 and iso-osmolar, lower-iodine concentration iodixanol-320. J Cardiovasc Comput Tomogr 2014;8:44-51 https://doi.org/10.1016/j.jcct.2013.12.003
- Achenbach S, Paul JF, Laurent F, Becker HC, Rengo M, Caudron J, et al. Comparative assessment of image quality for coronary CT angiography with iobitridol and two contrast agents with higher iodine concentrations: iopromide and iomeprol. A multicentre randomized double-blind trial. Eur Radiol 2017;27:821-830 https://doi.org/10.1007/s00330-016-4437-9
- Waser M, Kaufmann U, Luescher T, Meier B. Low or high iodine content of contrast medium for cardiac angiography? J Interv Cardiol 1998;11:113-116 https://doi.org/10.1111/j.1540-8183.1998.tb00106.x
- Zhang JJ, Hogstrom B, Malinak J, Ikei N. Effects of viscosity on power and hand injection of iso-osmolar iodinated contrast media through thin catheters. Acta Radiol 2016;57:557-564 https://doi.org/10.1177/0284185115595059
- Morcos SK, Thomsen HS. Adverse reactions to iodinated contrast media. Eur Radiol 2001;11:1267-1275 https://doi.org/10.1007/s003300000729
- Davenport MS, Khalatbari S, Dillman JR, Cohan RH, Caoili EM, Ellis JH. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material. Radiology 2013;267:94-105 https://doi.org/10.1148/radiol.12121394
- Bettmann MA. Frequently asked questions: iodinated contrast agents. Radiographics 2004;24 Suppl 1:S3-S10 https://doi.org/10.1148/rg.24si045519
- Namasivayam S, Kalra MK, Torres WE, Small WC. Adverse reactions to intravenous iodinated contrast media: a primer for radiologists. Emerg Radiol 2006;12:210-215 https://doi.org/10.1007/s10140-006-0488-6
- Park SH, Suh SH, Kim J, Kim EY, Kim DJ, Lee SK, et al. Clinical application of iopamidol (Pamiray® 300) for cerebral angiography. J Korean Soc Radiol 2007;57:121-127 https://doi.org/10.3348/jkrs.2007.57.2.121
- Kim MH, Choi S, Seon HJ, Kim YH, Kim JK, Park JG, et al. Clinical utility of iopamidol (Pamiray®370) for cardiac CT. J Korean Soc Radiol 2011;65:27-33 https://doi.org/10.3348/jksr.2011.65.1.27
- Kopp AF, Mortele KJ, Cho YD, Palkowitsch P, Bettmann MA, Claussen CD. Prevalence of acute reactions to iopromide: postmarketing surveillance study of 74,717 patients. Acta Radiol 2008;49:902-911 https://doi.org/10.1080/02841850802282811
- Palkowitsch P, Lengsfeld P, Stauch K, Heinsohn C, Kwon ST, Zhang SX, et al. Safety and diagnostic image quality of iopromide: results of a large non-interventional observational study of European and Asian patients (IMAGE). Acta Radiol 2012;53:179-186 https://doi.org/10.1258/ar.2011.110359